Australia Stock Exchange release from SUDA PHARMA : Appendix 4G and Corporate Governance Statement 2021
30/09/2021 06:59
Australia Stock Exchange release from SUDA PHARMA SUD.AX : Appendix 4G and Corporate Governance Statement 2021
Recent news on Arovella Therapeutics
See all newsBrief: Arovella Therapeutics Appoints Acting CEO
Brief: Arovella Therapeutics Says Michael Baker Resigns As CEO
Brief: Arovella Therapeutics Says Elizabeth Stoner Will Be Retiring As Interim Chair
Brief: Arovella Therapeutics Says IND For Ala-101 Accepted By FDA
Brief: Arovella Therapeutics Appoints Lachie Mallia As CFO